EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing Additive Interactions between Protective Factors Using Relative Risk Reduction Due to Interaction

Andrea Nova iD, Teresa Fazia iD, Luisa Bernardinelli

Medicina · 2024

DOI: 10.3390/medicina60071053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, 2024. Verfasst von Andrea Nova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: In the context of disease prevention, interaction on an additive scale is commonly assessed to determine synergistic effects between exposures. While the “Relative Excess Risk due to Interaction” represents the main measure of additive interaction between risk factors, in this study we aimed to extend this approach to assess additive interaction between factors known to prevent the event’s occurrence, such as medical interventions and drugs. Materials and Methods: We introduced and described the “Relative Risk Reduction due to Interaction” (RRRI) as a key measure to assess additive interactions between preventive factors, such as therapeutic interventions and drug combinations. For RRRI values closer to 1, the combination of exposures has a greater impact on reducing the event risk due to their interaction. As a purely illustrative example, we re-evaluated a previous investigation of the synergistic effect between statins and blood pressure-lowering drugs in preventing major adverse cardiovascular events (MACE). Moreover, simulation studies were used to empirically evaluate the performance of a robust Poisson regression model to estimate RRRI across different scenarios.

Results

In our example, the drug combination revealed a positive additive interaction in further reducing MACE risk (RRRI > 0), even if not statistically significant. This result is more straightforward to interpret as compared to the original one based on the RERI. Additionally, our simulations highlighted the importance of large sample sizes for detecting significant interaction effects.

Conclusion

We recommend RRRI as the main measure to be considered when exploring additive interaction effects between protective exposures, such as the investigation of synergistic effects between drug combinations or preventive treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsHumansProtective FactorsCardiovascular DiseasesAntihypertensive AgentsRisk FactorsRisk Reduction BehaviorRisk Assessment

Stichwörter der Autor:innen

additive interactioneffect modificationmoderationprotective factorssynergism

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsAntihypertensive Agents

Autor:innen und Institutionen

  • Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy.

ORCID-Profile: Andrea Nova, Teresa Fazia

Zitieren

APA

Nova, A., Fazia, T., & Bernardinelli, L. (2024). Assessing Additive Interactions between Protective Factors Using Relative Risk Reduction Due to Interaction. Medicina. https://doi.org/10.3390/medicina60071053

Vancouver

Nova A, Fazia T, Bernardinelli L. Assessing Additive Interactions between Protective Factors Using Relative Risk Reduction Due to Interaction. Medicina. 2024. doi:10.3390/medicina60071053

BibTeX
@article{Nova2024,
  author = {Nova, Andrea and Fazia, Teresa and Bernardinelli, Luisa},
  title = {Assessing Additive Interactions between Protective Factors Using Relative Risk Reduction Due to Interaction},
  journal = {Medicina},
  year = {2024},
  doi = {10.3390/medicina60071053}
}
Kostenlos starten →